Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
Inflammatory bowel disease (IBD) is a group of multifactorial and inflammatory infirmities comprised of two main entities: Ulcerative colitis (UC) and Crohn’s disease (CD). Classic strategies to treat IBD are focused on decreasing inflammation besides inducing and extending disease remission. Howeve...
Main Authors: | Paulo José Basso, Niels Olsen Saraiva Câmara, Helioswilton Sales-Campos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01571/full |
Similar Items
-
Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
by: Shinta Mizuno, et al.
Published: (2017-01-01) -
Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases
by: Heather Armstrong, et al.
Published: (2019-01-01) -
The microbiota in inflammatory bowel disease: current and therapeutic insights
by: Lane ER, et al.
Published: (2017-06-01) -
The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
by: Magdalena Stojek, et al.
Published: (2021-09-01) -
Fecal microbiota transplantation for ulcerative colitis
by: Katsuyoshi Matsuoka
Published: (2021-01-01)